| |
| EXECUTIVE OFFICERS |
D. Keith Grossman
President, Chief Executive
Officer and Director |
M. Wayne Boylston
Senior Vice President,
Chief Financial Officer
and Secretary |
Lawrence Cohen
President,
International Technidyne
Corporation |
Jeffrey W. Nelson
President,
Cardiovascular Division |
| BOARD OF DIRECTORS |
J. Donald Hill, M.D.
Chairman of the Board,
Thoratec Corporation |
Clinical Professor,
University of California
San Francisco
San Francisco, California |
Howard E. Chase
President,
The Hollandbrook Group, L.L.C.
Somerset, New Jersey |
J. Daniel Cole
General Partner,
Spray Venture Fund
Boston, Massachusetts |
|
|
Neil Dimick
Executive Vice President
and Chief Financial Officer
AmerisourceBergen Corporation,
Retired
Laguna Hills, California |
D. Keith Grossman
President,
Chief Executive Officer |
William M. Hitchcock
President,
Avalon Financial, Inc.
Houston, Texas |
George W. Holbrook, Jr.
Managing Partner,
Bradley Resources Company
Southport, Connecticut |
Daniel M. Mulvena
Founder and Owner,
Commodore Associates
Marblehead, Massachusetts |
| GENERAL COUNSEL |
David A. Lehman
Vice President &
General Counsel |
| PUBLIC ACCOUNTING
FIRM |
Deloitte & Touche LLP
San Francisco, California |
| STOCK TRANSFER AGENT |
Computershare Investor Services
350 Indiana Street, Suite 800
Golden, Colorado 80401 |
|
|
| ADDITIONAL INFORMATION |
For more information, please
write to:
Corporate Secretary
Thoratec Corporation
6035 Stoneridge Drive
Pleasanton, California 94588
www.thoratec.com |
| ANNUAL MEETING |
The Company’s annual meeting
of shareholders will be held
at 9:00 A.M. May 21, 2004. |
| TRADEMARKS |
Thoratec, the Thoratec logo,
Thoralon, TLC-II, HeartMate,
HeartPak and Vectra are
registered trademarks, and
Aria, Heart Hope and IVAD
are trademarks of Thoratec
Corporation. |
HEMOCHRON, ProTime
Surgicutt, Tenderlett, tenderfoot
and IRMA are registered
trademarks and TRUpoint is
a trademark of International
Technidyne Corporation. |
|
